Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme
Clinical trial NCT00005813 · COMPLETED
Trial details
- NCT number
- NCT00005813
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1997-03-01
- Primary completion
- 2003-01-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.